Functional Medicine for Suicide Prevention in a Primary Care Setting (Recorded Webinar)

Suicide is a public health issue of critical importance, one which merits our best, most focused efforts towards treatment and prevention, and stopping it at the primary care level is key. This webinar will introduce a biological framework for suicide prevention, one in which the concept of suicidality as the result of underlying nutritional, genetic, and psychosocial risk factors is explored. Scientific research supporting significant associations between malnutrition, essential fatty acid deficiencies, lithium deficiency, low cholesterol, and suicidality will be reviewed. Studies illustrating the benefits of targeted nutritional augmentation to mitigate risk factors will be presented; evidence-based interventions will be described, and a prevention model centered upon objective biologic measurement and a concept of biochemical individuality will be elucidated. Additionally, this on-demand webinar features an extended question and answer period following the main presentation.  This is an excellent opportunity to listen to some burning questions that our attendees of the live webinar asked and see what our expert speaker had to say. 

Credits: 1.25 contact hours; 0.25 are pharmacology
Expiration Date: June 30th, 2025

$12.50

LEARNING OBJECTIVES

After taking part in this educational activity, participants should be better able to:

1. Identify key nutritional, metabolic, and environmental factors associated with increased suicide risk, and how these factors represent therapeutic targets for functional interventions.
2. Elucidate the nutritional essentiality of the mineral lithium, mechanisms through which lithium confers neuroprotection and affective stabilization, and clinical indicators of lithium deficiency that may invite functional intervention for mental health and suicide prevention.
3. Describe how exogenous social and environmental factors interact with endogenous, biological factors to establish a continuum of suicide risk in susceptible individuals, and how a functional medicine approach to suicide prevention offers clinicians actionable stratagems for identifying and mitigating increased risk.

CE INFORMATION

Obtain Your Credits

To earn credits for this activity, you must complete all course components in the following order: 1) complete a three-question pre-test; 2) watch the course presentation video; 3) complete the course evaluation; 4) pass the post-test with a score of 2/3 (66.7%) or higher. You may retake the post-test until a passing score is achieved, at which point you will be able to view/print a copy of your certificate of completion. This online certificate will also be saved within your profile dashboard transcript for future access.

Designation Statement

NPACE designates this educational activity for a maximum of 1.25 contact hours, of which 0.25 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.

Accreditation Statement

Nurse Practitioner Associates for Continuing Education (NPACE) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC).

In addition to ANCC, NPACE is approved as a provider of continuing education in nursing by: the California Board of Registered Nursing, Provider Number CEP8720 and Florida CE Broker #50-1476.

DISCLOSURES

Faculty

Contributing faculty, James M. Greenblatt, M.D., have disclosed the following relevant financial relationships; Consultant for Pure Encapsulations and JayMac Pharmaceuticals.

Planners

All planners and contributors involved in this educational activity have disclosed no relevant financial relationships. 

Disclaimer

The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.

Disclosure of Unlabeled Use

This educational activity may mention the uses of products that are not approved by the FDA for the indication(s) being discussed. The presenter(s) are instructed to notify participants when they are discussing unapproved uses or investigational agents. The opinions related to unapproved uses of products are solely those of the presenter(s) and are not endorsed or recommended by NPACE. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Commercial Support

There is no commercial support for this activity.